Starpharma Holdings (Starpharma Holdings) Total Stockholders Equity : $23.06 Mil (As of Dec. 2023)

View and export this data going back to 2009. Start your Free Trial

What is Starpharma Holdings Total Stockholders Equity?

Starpharma Holdings's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $23.06 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Starpharma Holdings's Book Value per Share for the quarter that ended in Dec. 2023 was $0.56. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Starpharma Holdings's Debt-to-Equity for the quarter that ended in Dec. 2023 was 0.09.

Starpharma Holdings Total Stockholders Equity Historical Data

The historical data trend for Starpharma Holdings's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Starpharma Holdings Total Stockholders Equity Chart

Starpharma Holdings Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Total Stockholders Equity

Get a 7-Day Free Trial

29.44

21.62

47.63

34.01

23.37

Starpharma Holdings Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Stockholders Equity	Get a 7-Day Free Trial															39.40	34.01	27.68	23.37	23.06

Starpharma Holdings (OTCPK:SPHRY) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Starpharma Holdings's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(23.06	-	0)	/	41.1798
	=	0.56

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Starpharma Holdings's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.515	+	1.579)	/	23.06
	=	0.09

Starpharma Holdings Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Starpharma Holdings's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Starpharma Holdings (Starpharma Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Starpharma Holdings Ltd (OTCPK:SPHRY) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

SPHRF:USA PQ6:Germany SPL:Australia

Address

4-6 Southampton Crescent, Abbotsford, Melbourne, VIC, AUS, 3067

Website

https://www.starpharma.com

Starpharma Holdings Ltd is an Australia-based company engaged in the research, development, and commercialization of dendrimer products for pharmaceutical, life science, and other applications. It focuses on the development of VivaGel for the management and prevention of bacterial vaginosis and as a condom coating and VIRALEZE an antiviral nasal spray.